Expanding Market Reach Neoteryx’s recent partnership with CTC to provide remote blood sampling kits for virtual clinical trials indicates a growing demand for minimally invasive microsampling solutions in clinical research and telehealth markets, presenting opportunities for targeted sales of their devices to research organizations and telehealth providers.

Product Diversification The launch of new products such as the hemaPEN microbiopsy tool and the development of additional microsampling devices suggest there are opportunities to upsell and cross-sell to existing clients seeking minimally invasive sampling options across different research and diagnostic areas.

Research Support Expansion The introduction of the Research Support Program and the Microsampling Lab Directory demonstrates Neoteryx’s focus on facilitating laboratory partnerships, creating potential sales avenues with laboratories and healthcare providers engaged in remote specimen processing.

Global Diagnostic Penetration While the Mitra device is limited to research in the US, its use in clinical diagnostics outside the US indicates a significant international market expansion opportunity that can be targeted by sales teams to institutions involved in clinical diagnostics and personalized medicine.

Technology Leadership Neoteryx’s consistent innovation in microsampling technology combined with its positioning within the advanced biotech ecosystem suggests strong prospects for sales efforts that highlight cutting-edge solutions for remote sampling, especially to organizations prioritizing remote healthcare and minimally invasive diagnostics.